Evidence map›Paper›PMID 33802745›Full record

ArticleBiomolecules2021

New Generation of Hybrid Materials Based on Gelatin and Bioactive Glass Particles for Bone Tissue Regeneration.

Amel Houaoui, Agata Szczodra, Mari Lallukka, Lamia El-Guermah, Remy Agniel, Emmanuel Pauthe, Jonathan Massera, Michel Boissiere

Abstract read
In one paragraph

Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Amel HouaouiBiomaterials for Health Research Group, ERRMECe, Equipe de Recherche sur les Relations Matrice Extracellulaire-Cellules (EA1391), Institut des Matériaux I-MAT (FD4122), CY Tech, CY Cergy Paris Université, Maison Internationale de la Recherche (MIR), rue Descartes, 95001 Neuville sur Oise CEDEX, France.ORCID 0000-0002-8030-7592
Agata SzczodraTampere University, Faculty of Medicine and Health Technology, Laboratory of Biomaterials and Tissue Engineering, Korkeakoulunkatu 3, 33720 Tampere, Finland.
Mari LallukkaTampere University, Faculty of Medicine and Health Technology, Laboratory of Biomaterials and Tissue Engineering, Korkeakoulunkatu 3, 33720 Tampere, Finland.ORCID 0000-0001-8360-7665
Lamia El-GuermahBiomaterials for Health Research Group, ERRMECe, Equipe de Recherche sur les Relations Matrice Extracellulaire-Cellules (EA1391), Institut des Matériaux I-MAT (FD4122), CY Tech, CY Cergy Paris Université, Maison Internationale de la Recherche (MIR), rue Descartes, 95001 Neuville sur Oise CEDEX, France.
Remy AgnielBiomaterials for Health Research Group, ERRMECe, Equipe de Recherche sur les Relations Matrice Extracellulaire-Cellules (EA1391), Institut des Matériaux I-MAT (FD4122), CY Tech, CY Cergy Paris Université, Maison Internationale de la Recherche (MIR), rue Descartes, 95001 Neuville sur Oise CEDEX, France.ORCID 0000-0002-2956-7532
Emmanuel PautheBiomaterials for Health Research Group, ERRMECe, Equipe de Recherche sur les Relations Matrice Extracellulaire-Cellules (EA1391), Institut des Matériaux I-MAT (FD4122), CY Tech, CY Cergy Paris Université, Maison Internationale de la Recherche (MIR), rue Descartes, 95001 Neuville sur Oise CEDEX, France.
Jonathan MasseraTampere University, Faculty of Medicine and Health Technology, Laboratory of Biomaterials and Tissue Engineering, Korkeakoulunkatu 3, 33720 Tampere, Finland.
Michel BoissiereBiomaterials for Health Research Group, ERRMECe, Equipe de Recherche sur les Relations Matrice Extracellulaire-Cellules (EA1391), Institut des Matériaux I-MAT (FD4122), CY Tech, CY Cergy Paris Université, Maison Internationale de la Recherche (MIR), rue Descartes, 95001 Neuville sur Oise CEDEX, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hybrid scaffolds based on bioactive glass (BAG) particles (<38 µm), covalently linked to gelatin (G*) using 3-glycidoxypropyltrimethoxysilane (GPTMS), have been studied for bone bioengineering. In this study, two glass compositions (13-93 and 13-93B20 (where 20% of the SiO

Indexed as

AnimalsBiocompatible MaterialsBone and BonesBone RegenerationCell LineCell ProliferationDurapatiteGelatinGlassMiceOsteoblastsSilanesSilicon DioxideTissue EngineeringTissue Scaffolds3-glycidoxypropyltrimethoxysilaneBiocompatible MaterialsDurapatiteGelatinSilanesSilicon Dioxidebioactive glassbone tissue engineeringgelatinGPTMShybrid scaffold

Identifiers

PMID33802745
PMCPMC8002581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.